ReviewNature methods2026
Multifactor authentication in extracellular vesicle analysis: methods and approaches to address the heterogeneity problem.
Review in Nature methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Extracellular vesicles (EVs) are essential for intercellular communication and various physiological processes; however, they are difficult to reliably identify and characterize owing to their inherent heterogeneity. To address this challenge, we adapt the concept of multifactor authentication (MFA) from computer science, and apply it to EV analysis. Similar to requiring multiple credentials to confirm digital identity, MFA in EV research integrates structural and molecular features to validate vesicle identity within heterogeneous mixtures and resolve subpopulations down to the single-EV level. By cross-validating across distinct factors and standardizing a multistep pipeline, MFA has the potential to enhance specificity, reliability, reproducibility and biological interpretability in EV analysis. Although no single approach fulfills all MFA criteria, several existing approaches embody MFA-like features. In this Perspective, we introduce MFA, discuss MFA-like approaches for EV subpopulation and single-EV analyses, highlight implications for EV biology and translational applications, and outline future directions for implementing an idealized MFA framework.
Indexed as
Identifiers
42014877What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.